Trial Profile
Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Aug 2019
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Registrational; Therapeutic Use
- Sponsors LEO Pharma
- 30 Jul 2019 Primary endpoint (Complete resolution of actinic keratosis (AK)) has been met as per results published in the Journal of the American Academy of Dermatology
- 30 Jul 2019 Results published in the Journal of the American Academy of Dermatology
- 15 Mar 2017 Status changed from active, no longer recruiting to completed.